Breaking News

Pacific Biomarkers Merges with Neomed-Labs

Benoit Bouche to serve as chief executive of the combined company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ampersand Capital Partners has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company Neomed-Labs. This merger brings together two bioanalytical contract research organizations (CROs) with unrivaled credentials in immunology and particular expertise in assay development, custom biomarker validation, and high-throughput clinical sample testing.    Based in Seattle and founded in 1989, Pacific Biomarkers provides specialty biomarker development and central ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters